The Impact of Schizophrenic Patient Functionality on Service Utilization and CostBySandra L. Tunis, PhDJuly 1st 1999
Evaluation of Outcomes for Atypical Antipsychotic Therapy and Psychosocial Rehabilitation in a Community Mental Health CenterByDouglas Noordsy, MDJuly 1st 1999
Modeling of Annual Treatment Costs and Health Outcomes of Antipsychotic Agents for Schizophrenic PopulationsByJosephine Mauskopf, PhDJuly 1st 1999
Assessment of Quality-of-Life Outcomes in Schizophrenic PatientsByAnthony F. Lehman, MD, MSPHJuly 1st 1999
The Emerging Role of Psychiatric PharmacistsByLawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FASCPJuly 1st 1999
